given little evidence of effectiveness for promoting repair. In general, the treatment of these drugs is primarily aimed at reducing the relapses and slowing the development of disability. 3 To date, no MS therapy has shown any significant ability to improve functioning in patients with fixed disability.
Fasudil, one of the most thoroughly studied Rho kinase (ROCK) inhibitors, has been shown to have beneficial effects in various neurodegenerative diseases. More importantly, previous studies by our group and others have demonstrated that Fasudil exhibited protective effect in models of Parkinson's disease (PD), 4 amyotrophic lateral sclerosis (ALS), 4 Alzheimer's disease (AD), 5, 6 Huntington disease, 7 and spinal muscular atrophy (SMA). 8 These evidences indicate that Fasudil has a wide application prospect in central and peripheral nervous system. However, the role of Fasudil on myelin repair has not been evaluated. The demyelination model induced by cuprizone (CPZ), known as one of the toxic-based demyelination models, is often used to mimic the pathology of human MS 9 The CPZ induces demyelination in the corpus callosum, superior cerebellar peduncles, and cerebral cortex by selective loss of oligodendrocytes. 10 Remarkably, some aspects of the histological pattern in CPZ-induced demyelination are similar to those found in MS A number of researches have indicated that CPZ exposure also provokes abnormal behaviors, and mood and cognitive deficits that are believed to be a direct result of demyelination.
11-13
Thus, CPZ-induced demyelination shows significant relevance for reproducing some key features of demyelinating diseases and can be used as a tool for analyzing mechanisms of demyelination/ remyelination 9 and testing the potential therapeutics. The aim of the present study was to investigate the therapeutic effect of Fasudil in CPZ-induced demyelination and to explore the underlying mechanisms of remyelination and/or neuroprotection.
| MATERIAL S AND ME THODS

| Animals
A total of 24 male C57BL/6 mice (10-12 weeks old) were purchased from Vital River Laboratory Animal Technology Co., Ltd. All animal procedures were performed in accordance with the guidelines approved by the International Council for Laboratory Animal Science.
This study was approved by the Council for Laboratory and Ethics
Committee of Shanxi University of Traditional Chinese medicine, Taiyuan, China. All mice were maintained and housed under pathogen-free conditions with constant temperature (25 ± 2°C) in a reversed 12:12 hour light/dark cycle.
| CPZ-induced demyelination
Mice were fed with standard diet or chow diet supplemented with 0.2% (w/w) CPZ (Sigma-Aldrich) ad libitum for a total of 6 weeks to induce demyelination. Mice were randomly divided into three groups (n = 8 each group): (a) normal group fed standard diet; (b) CPZ group fed CPZ and intraperitoneally (ip) injected with normal saline (NS 200 μL) after 4 weeks for consecutive 13 days; (c) Fasudil-treated CPZ group, which were ip injected with Fasudil (40 mg/kg/d) after 4 weeks for consecutive 13 days. Fasudil (from Tianjin Chase Sun Pharmaceutical Co., Ltd) was dissolved in NS. The body weight of mice was monitored every two days. For simplicity of presentation, the normal group, CPZ group, and Fasudil-treated CPZ group will be described as normal, CPZ, and Fasudil, respectively. Pole test was used to assess the locomotor coordination of mice. 15 After the end of the 6th week, each mice was placed tenderly head-up facing the apex of the vertical pole. The time taken to reach the bottom of the pole after climbing over (touchdown time) was recorded for analysis. The cut-off time was 60 seconds for touchdown time. In every test, two consecutive trials were conducted and the average time of two trials was recorded.
| Behavioral tests
| Tissue preparation
At the end of the experiment, half of the mice in each group were deeply anaesthetized and then perfused transcardially with saline, followed by 4% paraformaldehyde (PFA) in phosphate buffer (PBS, 0.01 M, pH = 7.4). Brains were isolated carefully and postfixed in the same PFA for 2 hours at 4°C. Afterward, brains were treated with 30% w/v sucrose solution at 4°C for 24 hours and embedded with OCT. Brain coronal sections were sliced using a cryostat microtome (Leica CM1850) at a thickness of 10 μm for immunofluorescence procedure. The rest of mice in each group were deeply anaesthetized and perfused transcardially with saline, without 4% PFA. Brains were removed, and the corpus callosums were dissected out. The samples were collected for ELISA and Western blot.
| Myelin staining
Luxol fast blue (LFB) staining: LFB staining was used to examine the area of demyelination in corpus callosum according to the previous researches. 16 The slides were incubated in 0.1% LFB solution for 18 hours at 60°C. Excess dye was washed away, and slides were hydrated with 95% ethanol. After differentiated by 0.05% lithium carbonate solution for 30 seconds, slices were dipped in 70% alcohol, and stopped immediately with distilled water. Thereafter, slides
were dehydrated in a graded ethanol and fixed by dimethylbenzene.
The slides were scanned and captured using a light microscope equipped with a digital camera (Leica camera). ImageJ software was used to evaluate the extent of demyelination.
Black Gold II staining: The Black Gold II staining (Black Gold II myelin staining kit, Millipore) is widely used for visualizing myelin morphology with good resolution of individual myelin fibers. 17, 18 In short, prewarmed Black Gold II solution (0.3% in NS) was added onto 4% PFA-fixed sections and incubated at 60°C in water bath for 25 minutes until desired signals developed. The slides were then fixed in preheated 1% sodium thiosulfate (1% in ddH 2 0) at 60°C for 3 minutes. After rinsing with Milli-Q water, the slides were incubated with 0.1% Cresyl Violet at RT for 3 minutes. Slides were dehydrated using a series of gradated alcohols, cleared in xylene for 2 minutes, and coverslipped with mounting media. The area of demyelination in the corpus callosum was measured using Image Pro Plus software (Media Cybernetics) and represented as percent demyelination.
Myelin basic protein (MBP) immunohistochemistry staining: The slides were blocked with 1% BSA/PBS at RT for 0.5 hours and incubated with anti-MBP (1:500, Abcam) overnight at 4°C, followed by incubation with corresponding secondary antibody at RT for 2 hours.
As a negative control, additional slides were treated similarly, but the primary antibodies were omitted. Results were determined using
Image-Pro Plus software in a blinded fashion. Quantification was performed on three sections per mouse.
| Preparation of splenic mononuclear cells
At the end of experiment, fresh spleens were isolated under aseptic conditions. The weight and volume of spleens were recorded. 
| Flow cytometry analysis
Splenic MNCs were fixed with 4% PFA for 20 minutes and then stained in 1% BSA-PBS (surface antigen) or 0.3% saponin/1% BSA-PBS (intracellular staining) for 20 minutes at RT with the following antibodies: Alexa Fluor B220, FITC-CD4/PE-IFN-γ, and CD4/PE-IL-17
(eBioscience). At least 10 000 events were collected using flow cytometer (BD Biosciences), and data were analyzed using Cell Quest software. Life Sciences) and analyzed using Quantity Software (Bio-Rad).
| MOG antibody assay
| Immunohistochemical staining
Brain coronal sections were used to perform immunohistochemical 
| Western blot analysis
RIPA lysis buffer (Beyotime Institute of Biotechnology) was used to extract protein from brains. Following centrifugation at 12 000 g for 20 minutes at 4°C, the extract was collected, and protein con- 
| Cytokine ELISA
The concentrations of IFN-γ, IL-10, IL-17, IL-6, TNF-α (PeproTech Inc), and IL-1β (Invitrogen Inc) were measured by a sandwich ELISA kits following the manufacturer's instructions.
Determinations were performed in at least three independent experiments, and the concentrations of cytokines were expressed as pg/mL.
| Data analysis
For all experiments, the animals were assigned to different group by random selection. The experiments in this study were repeated two or three times. All statistical analyses were performed by one-way analysis of variance (ANOVA) followed by a Bonferroni post hoc test for multiple comparisons using GraphPad Prism 5 software (Cabit Information Technology Co., Ltd.). Results are expressed as the mean ± SEM. P value <0.05 was considered statistically significant.
| RE SULTS
| Establishment of CPZ-induced demyelination model
The CPZ model is an established mouse model of experimental demyelination by selective apoptosis of oligodendrocytes, which peaks around 2-3 weeks of exposure followed by massive loss of myelin at 4-5 weeks. In the current study, mice were first fed with a normal diet or chow diet supplemented with 0.2% (w/w) CPZ for 4 weeks before Fasudil treatment ( Figure 1A ). Cuprizone feeding significantly decreased the body weight of mice compared to mice with normal diet in the first week after CPZ feeding ( Figure 1B ). In the following 
| The improvement of behavior and demyelination by Fasudil
To Quantitative data are mean ± SEM and analyzed for four mice in each group. Photographs are representative maps of mice brain from different groups. *P < 0.05, **P < 0.01, ***P < 0.001 P < 0.01), which was significantly shortened by Fasudil treatment compared to the CPZ group ( Figure 2C , P < 0.05). After the behavioral test, mice were decapitated and brain tissues were collected to detect pathologic change.
The effects of Fasudil on the improvement of demyelination were examined by Black Gold II staining, LFB staining, and MBP immunostaining. In CPZ group, both LFB and Black Gold II staining in the corpus callosum was significantly weaker than in normal group ( Figure 2D , P < 0.001, respectively). Similarly, CPZ feeding reduced the expression of MBP in the cingulum ( Figure 2D , P < 0.001) and by western blot ( Figure 2E , P < 0.001) as compared with normal group.
These results demonstrated an evident damage of myelin occurred in the corpus callosum and cingulum after 6 weeks of CPZ feeding, which should be related to behavioral changes. Fasudil treatment significantly protected myelin damage or promoted myelin regeneration, representing an increase in both LFB and Black Gold II staining ( Figure 2D , P < 0.001, respectively) and MBP expression by immunohistochemistry staining ( Figure 2D , P < 0.05) and western blot ( Figure 2E , P < 0.001), as compared to CPZ-fed group. To further understand the effect of Fasudil on the oligodendrocytes, mature oligodendrocytes were counted by O4 immunostaining. As shown in Figure 2F , the number of O4 + mature oligodendrocyte showed a decrease in mice fed with CPZ (P < 0.001).
F I G U R E 3
On the contrary, the increase in O4 + oligodendrocyte was found at 2 weeks of Fasudil treatment compared to CPZ group ( Figure 2F , P < 0.001). These results suggested that Fasudil treatment ameliorated the behavioral changes and promoted the myelin protection/ regeneration in CPZ-mediated demyelination lesion. However, myelin repair in Fasudil-treated mice did not accompany with the increase in body weight at the same time.
| The regain of spleen volume by Fasudil
Unexpectedly, the spleen size in CPZ-fed mice was remarkably reduced, and the weight of spleens and the number of splenic MNCs were reduced when compared to normal mice ( Figure 3A , P < 0.001).
However, Fasudil treatment significantly increased the volume and weight of spleens, and number of splenic MNCs ( Figure 3A , P < 0.05).
| The inhibition of MOG-specific antibody by Fasudil
It is noteworthy that the presence of serum autoantibodies to CNSspecific proteins was observed in a group of neural or demyelinating injury diseases. 19 Due to the vulnerability of oligodendrocytes in CPZ model, we detected MOG-specific antibody in serum, culture supernatants, and brain homogenates. As demonstrated in 
| The inhibition of neuroinflammation in the brain by Fasudil
The CPZ model is characterized by primary and reversible demyelination, due to peripheral immune-independent myelin injury, 20 accompanied by mature oligodendrocyte damage and activation of microglia. 21 Previous studies showed that oligodendrocytes are highly vulnerable in an inflammatory microenvironment. 22, 23 Therefore, the neuroinflammation is considered to worsen the se- an association between the microglia phenotype and inflammatory cytokines. As shown in Figure 6D , the levels of main inflammatory cytokines IL-1β and IL-6 were elevated in CPZ-fed mice (P < 0.001 respectively), which was inhibited by Fasudil treatment (P < 0.001, respectively). The change of TNF-α had similar trend, though the difference did not reach statistical significance ( Figure 6D) . These 
| The induction of neurotrophic environment in the brain by Fasudil
Neurotrophin signaling impacts development and survival of oligodendrocyte lineage cells. In this study, we find that CPZ feeding resulted in the enrichment and increase in GFAP + astrocytes in the corpus callosum and striatum compared to normal group, which can be further enhanced by Fasudil treatment (Figure 7A ), revealing that 
| D ISCUSS I ON
Previous works have indicated that Fasudil has neuroprotective effects in several neurodegenerative diseases, like experimental autoimmune encephalomyelitis (EAE), [24] [25] [26] PD, 27,28 ALS, 29 and AD. 6 The mechanisms of Fasudil action include anti-inflammation, synaptogenesis, and M2 polarization in microglia. 30 In addition, Fasudil ameliorated the severity of EAE, accompanied by rebalance of helper T cell 1 (Th1) and Th17, macrophage polarization from M1 to M2 phenotype, and less infiltration of inflammatory cells in spinal cord. 24, 31 By regulating peripheral immune dysfunction, Fasudil attenuated neuroinflammation, demyelination, and axonal loss in EAE model. 32 In the present study, we demonstrated that CPZ feeding resulted in the demyelination in The spleen is one of the most important peripheral immune organs, which is frequently affected in infectious diseases. 33 In this CPZ-induced demyelinating model, spleen atrophy was observed compared to normal mice. To exclude the deviation of spleen atrophy, the weight of spleens and the number of splenocytes were also examined, giving the same results with atrophy of spleen.
Consistent with our results, a very recent study also found that CPZ exposure also induced spleen atrophy. 34 At present, we lack direct experimental evidence to elucidate the cellular and molecular mechanisms for spleen atrophy in CPZ-induced demyelination.
Previous studies have shown that splenic atrophy is an important feature for stroke-induced peripheral immunodepression within the first few days, which is characterized by reduced organ size and reduced number of spleen cells, 35, 36 and this decrease in spleen size is due to apoptosis of cells and loss of functional centers within spleen. 34 It was reported that patients undergoing acute phase of ischemic stroke (<24 hours) exhibited marked atrophy of spleen, as measured by magnetic resonance imaging (MRI). 37 Further in- tracer leakage, and serum extravasation. [43] [44] [45] [46] Recent study indicated that BBB hyperpermeability precedes demyelination in CPZ-demyelinating model. 47 BBB integrity was compromised in mice treated with CPZ for 4 weeks, as indicated by extravasation of Evans blue dye into the CNS. 48 In addition, the integrity and permeability of BBB depend on tight junctions that are sensitive to disruption triggered by inflammatory mediators. 49 As expected, the expression Antibodies to galactocerebroside (GalC) and MOG can play a major role in destabilizing myelin through MBP breakdown. 55 To date, most data indicate that B cell activation after a traumatic CNS injury, especially spinal cord injury (SCI), causes pathology leading to impaired recovery of neurological function. 53, 54 In the current study, human MS patients have circulating antibodies specific for both human and mouse MOG. MOG-specific antibodies from MS patients can contribute to EAE exacerbation in a transfer model. 56 Our results showed that MOG antibody was capable of being detected in the brain of mice fed with CPZ, providing a possibility for specific MOG antibodymediated oligodendrocyte damage. Therefore, it is logical to explore inhibition of B cell function as a therapeutic option. Whether MOG antibody is a mere epiphenomenon of brain injury or contributes to the late sequelae of demyelination is unclear. Further investigation remains to be needed, including the antibody-mediated pathology in CPZ-induced demyelination, complement or antibody-dependent cellular cytotoxicity, and mechanism of Fasudil in antibody regulation.
Further understanding of antibody-mediated pathology may suggest novel therapeutic strategies in demyelinating disease.
It has been noted that the activation of microglia in numerous researches of CPZ-induced demyelination. [57] [58] [59] In addition, oligodendrocytes are highly vulnerable in an inflammatory environment. 60 In this study, we found that Iba-1 + microglia were aggregated or increased in the corpus callosum and striatum, demonstrating that CPZ induced microglia activation, which is consistent with other studies. 61 Activated microglia are known to contribute to neurodegeneration via various cytotoxic molecules. 62 On the other hand, activated microglia also could play important roles in protection against various pathological conditions in the CNS. 59 
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